Amarin Corp PLC (NAS:AMRN)
$ 0.5578 0.0055 (1%) Market Cap: 229.44 Mil Enterprise Value: -72.52 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 37/100

Amarin Corporation plc - Special Call Transcript

Mar 18, 2019 / 09:00PM GMT
Release Date Price: $19.3 (-5.07%)
Operator

Greetings, and welcome to Amarin's discussion on Transforming the Unprecedented REDUCE-IT Study Results into Clinical Practice. (Operator Instructions) It is now my pleasure to introduce Elisabeth Schwartz, Senior Director of Investor Relations for Amarin. Please go ahead, Elisabeth.

Elisabeth Schwartz
Amarin Corporation plc - Senior Director of IR

Thank you. Welcome to today's discussion on Transforming the Unprecedented REDUCE-IT Study Results into Clinical Practice. The slides accompanying this call are on our Investors section of www.amarincorp.com. If interested in (inaudible), please reference the forward-looking statements section in the reference slide on Amarin's website.

I would like to turn the call over to Dr. Craig Granowitz, the Chief Medical Officer of Amarin.

Craig B. Granowitz
Amarin Corporation plc - Chief Medical Officer & Senior VP

Thank you, Elisabeth, and thank you all to our panelists and the listeners who called

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot